Table 3 |
||||||
|
Overall and age-specific final attack rates for pH1N1 for different vaccination scenarios for R0 1.4 and an 8-week vaccine campaign length. |
||||||
|
Vaccination start date |
Vaccination strategy |
Attack rate,% (% reduction vs. None) |
||||
|
|
||||||
|
All ages |
0-4 |
5-17 |
18-54 |
≥55 |
||
|
|
||||||
|
None |
None |
48.3 |
35.1 |
78 |
47.5 |
24.1 |
|
|
||||||
|
24-Aug |
AC |
8.0 (83) |
4.6 (87) |
12.0 (85) |
8.9 (81) |
3.2 (87) |
|
|
||||||
|
UC |
10.1 (79) |
6.7 (81) |
20.0 (74) |
8.8 (81) |
4.0 (83) |
|
|
|
||||||
|
PC |
6.1 (87) |
7.8 (78) |
1.1 (99) |
8.5 (82) |
5.0 (79) |
|
|
|
||||||
|
PC+ |
4.3 (91) |
5.0 (86) |
0.9 (99) |
6.2 (87) |
3.2 (87) |
|
|
|
||||||
|
28-Sep |
AC |
25.5 (47) |
16.0 (54) |
42.3 (46) |
25.7 (46) |
10.9 (55) |
|
|
||||||
|
UC |
26.8 (44) |
18.3 (48) |
49.2 (37) |
24.7 (48) |
11.7 (51) |
|
|
|
||||||
|
PC |
14.1 (71) |
14.0 (60) |
9.4 (88) |
18.3 (62) |
9.5 (61) |
|
|
|
||||||
|
PC+ |
12.1 (75) |
12.3 (65) |
7.7 (90) |
15.9 (67) |
8.2 (66) |
|
|
|
||||||
|
26-Oct |
AC |
42.0 (13) |
28.9 (18) |
69.8 (10) |
41.1 (13) |
19.7 (18) |
|
|
||||||
|
UC |
42.0 (13) |
29.8 (15) |
71.5 (8) |
40.3 (15) |
19.9 (17) |
|
|
|
||||||
|
PC |
37.7 (22) |
29.3 (16) |
54.1 (31) |
39.3 (17) |
20.1 (17) |
|
|
|
||||||
|
PC+ |
36.4 (25) |
28.5 (19) |
52.0 (33) |
38.0 (20) |
19.5 (19) |
|
|
|
||||||
|
23-Nov |
AC |
47.4 (2) |
34.1 (3) |
77.1 (1) |
46.5 (2) |
23.4 (3) |
|
|
||||||
|
UC |
47.4 (2) |
34.2 (2) |
77.2 (1) |
46.4 (2) |
23.4 (3) |
|
|
|
||||||
|
PC |
47.0 (3) |
34.4 (2) |
75.2 (4) |
46.5 (2) |
23.6 (2) |
|
|
|
||||||
|
PC+ |
46.8 (3) |
34.3 (2) |
74.9 (4) |
46.3 (3) |
23.5 (2) |
|
|
|
||||||
|
Attack rate is defined here as the total number of infections. 'AC' indicates the actual vaccination coverage for pH1N1 in the GVRD, 'UC' the uniform coverage vaccination strategy, 'PC' the parents and children vaccination strategy, and 'PC+' the PC/actual sequence strategy |
||||||
|
Conway et al. BMC Public Health 2011 11:932 doi:10.1186/1471-2458-11-932 |
||||||
